Filing Details

Accession Number:
0001104659-20-136481
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-16 21:00:59
Reporting Period:
2020-12-14
Accepted Time:
2020-12-16 21:00:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1621227 Adaptimmune Therapeutics Plc ADAP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1577539 Gavin Wood C/O Adaptimmune Therapeutics Plc,
60 Jubilee Avenue, Milton Park
Abingdon X0 OX14 4RX
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share Acquisiton 2020-12-14 24,000 $0.69 57,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by Gavin Wood. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc.
  2. The 24,000 ordinary shares reported in Column 4 are represented by 4,000 ADSs.
  3. The price reported in Column 4 of $0.6896 per ordinary share is derived from the purchase price paid on December 14, 2020 of $4.1375 per ADS divided by six.
  4. The 57,000 ordinary shares reported in Column 5 include 33,000 ordinary shares represented by 5,500 ADSs owned by Mr. Wood prior to the purchase reported in Column 4. These shares are held in the form of ADSs by Mr. Wood.